Search Results for "Stool Ez1"
Original Source: Five commercial DNA extraction systems tested and compared on a stool sample collection.
In this study, 5 different commercial DNA extraction systems were tested on a stool sample collection containing 81 clinical stool specimens that were culture-positive for diarrheagenic Escherichia coli, Campylobacter jejuni, Salmonella enterica, or Clostridium difficile. The purified DNAs were analyzed by polymerase chain reaction (PCR) directed toward the relevant organisms. The results showed that conventional PCR combined with the extraction systems BioRobot EZ1 (Qiagen, Hilden, Germany), Bugs'n Beads (...
Matching Channels
Disorders of Calcium Concentration
Calcium (Ca) is required for the proper functioning of muscle contraction, nerve conduction, hormone release, and blood coagulation. In addition, proper Ca concentration is required for various othe...
Matching News
Treating C. difficile Infection With RePOOPulate
A synthetic "poop" developed at the University of Guelph can cure nasty gastrointestinal infections caused by Clostridium difficile, a toxin-producing bacterium. A study on the artificial stool was pu...
Donated human stool safely and effectively treats C. difficile infections, study suggests
A novel therapy that uses donated human stool to treat the deadly and contagious C.diff infection is safe and highly effective, according to a new study. The healthy stool, when mixed with warm tap wa...
Researchers Create Synthetic Stool That Cures C. Diff
Canadian scientists have created an artificial stool that cures bouts of Clostridium difficile (C. diff). This toxin-producing bacterium causes serious intestinal infections responsible for the deaths...
Human stool treatment upends race to treat colon germ
(Reuters) - Drugmakers racing to develop medicines and vaccines to combat a germ that ravages the gut and kills thousands have a new challenger: the human stool.
Using human stool to treat C. diff is safe, effective
A novel therapy that uses donated human stool to treat the deadly and contagious C.diff infection is safe and highly effective, according to a Henry Ford Hospital study.
Human Stool Transplant Effective Treatment For C-diff
An unconventional therapy that uses donated human stool to treat the highly contagious and potentially fatal C.diff is safe and beneficial, according to a new study being presented at the annual Infec...
Researchers Advocate 'RePOOPulating' the Gut for Eradication of Clostridium difficile Infection
Fecal bacteriotherapy (stool transplant) can be effective in treating recurrent Clostridium difficile infection, but concerns of donor infection transmission and patient acceptance limit its use. Petr...
Novel therapy that uses human stool is safe and highly effective in treating C.diff infection
A novel therapy that uses donated human stool to treat the deadly and contagious C.diff infection is safe and highly effective, according to a Henry Ford Hospital study.
Matching PubMed Articles
Culturing Stool Specimens for Campylobacter spp., Pennsylvania, USA.
In 2010, we surveyed 176 clinical laboratories in Pennsylvania regarding stool specimen testing practices for enteropathogens, including Campylobacter spp. Most (96.3%) routinely test for Campylobacte...
General adoption of the screening tests for colorectal cancer (CRC) by patients, health care professionals, medical centers, and third party payers rests on a favorable assessment of value. Reported c...
BACKGROUND: A recent post-infectious rat model with Campylobacter jejuni 81-176 has replicated the events noted in humans with post-infectious irritable bowel syndrome (IBS). In this study, we test wh...
Abstract Objective. Stool antigen tests using monoclonal antibody are used to test the results of eradication therapy of Helicobacter pylori. A newly developed test using multiple monoclonal antibodie...
We succeeded in stimulation of Strongyloides stercoralis larvae excretion in stool by oral administration of a single dose of 400 mg albendazole to strongyloidiasis patients. This result overcame the...
